Sort
82,697 grants matching “vaccine development”
Johns Hopkins Excellence in Pathogenesis and Immunity Center for SARS-CoV-2 (JH-EPICS)
$4,067,207Sabra L Klein · Johns Hopkins University · U54 · FY2020 · CA
Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component C: Clinical Core
$4,065,402Jill Frankenfield · University Of Maryland Baltimore · N01 · FY2025 · AI
Task C28: Rhesus Macaque Oral Infection Model for Poliovirus
$4,063,461Chen Zheng · · N01 · FY2015 · AI
UCLA AIDS Prevention and Treatment Clinical Trials Unit
$4,062,344Judith S. Currier · University Of California Los Angeles · UM1 · FY2020 · AI
Novel Adenovirus Vector-Based Vaccines for HIV-1
$4,058,366Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2007 · AI
CCR Collaborative Bioinformatics Resource
$4,057,258Mariam Malik · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA
Targeting Neutralizing Epitopes in the HIV Envelope
$4,056,563Susan W Barnett · Novartis Vaccines And Diagnostics, Inc. · P01 · FY2007 · AI
Antibody, Epitope and Machine Learning Core
$4,054,931Chang C Liu · University Of California-Irvine · U19 · FY2024 · AI
Determinants of HIV Transmission
$4,053,572Susan Little · University Of California, San Diego · P01 · FY2008 · AI
Core C: Structure Core
$4,043,107Jason Scott McLellan · Washington University · U19 · FY2024 · AI
Administrative Supplements for NIAID Regional Biocontainment Laboratories (RBL)
$4,039,853Farhang Alem · George Mason University · G20 · FY2022 · AI
Clinical Trials of Vaccines for Respiratory Syncytial Virus and Related Viruses
$4,039,585Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Cancer Immunotherapy
$4,037,445James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
A Methamphetamine Conjugate Vaccine: From Manufacturing to IND
$4,033,814Misty Ward Stevens · Intervexion Therapeutics, Llc · U01 · FY2016 · DA
Malaria Vaccine: Pfs25-rEPA
$4,033,409Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
The University of North Carolina Center for AIDS Research
$4,032,470Ronald I Swanstrom · Univ Of North Carolina Chapel Hill · P30 · FY2019 · AI
DEVELOPMENT OF ANTHRAX VACCINE FORMULATIONS
$4,028,420John Troyer · Pharmathene, Inc. · N01 · FY2017 · AI
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies
$4,026,004Pamela J Bjorkman · California Institute Of Technology · P01 · FY2025 · AI
NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF HCMV-TR3∆PP71 HIVGAG FOR CLINICAL TRIALS
$4,025,316Nancy Lin · Advanced Bioscience Laboratories, Inc. · N01 · FY2014 · AI
Global innate immune responses to HIV-1 infection
$4,024,406John A T Young · Salk Institute For Biological Studies · P01 · FY2012 · AI
LC: HIV PREVENTION TRIALS NETWORK
$4,024,293Susan H Eshleman · Johns Hopkins University · UM1 · FY2024 · AI
Task V03: Immunogenicity and Efficacy Testing of Medical Countermeasures (Vaccines and Other Biologics) against BSL-4 Pathogens in Non-Human Primates
$4,017,825Thomas Rudge · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2020 · AI
Mechanisms and Duration of Immunity to SARS-CoV-2
$4,017,422Scott Dexter Boyd · Stanford University · U54 · FY2020 · CA
Development of a COVID-19 Vaccine
$4,015,904Steven Reed · Hdt Bio Corporation · N01 · FY2021 · AI
Northwestern CORE Clinical Research Site: Trans-omics for HIV/AIDS Research
$4,014,846Steven M Wolinsky · Northwestern University At Chicago · U01 · FY2023 · HL